Latest Regulatory Approval News

Centaurus Metals has secured the final mining lease for its Jaguar Nickel Project in Brazil, clearing a major regulatory hurdle and moving closer to a Final Investment Decision and project development.

Trigg Minerals is advancing its strategy to list on the U.S. NASDAQ, weighing options including a dual listing and potential SPAC mergers, while planning a name change to reflect its evolving focus.

Toubani Resources has locked in a comprehensive A$395 million funding package, fully financing the development of its Kobada Gold Project in Mali and positioning itself as a future high-margin West African gold producer.

Toubani Resources has locked in a transformative A$395 million funding package to advance its Kobada Gold Project in Mali, setting the stage for production to commence by the third quarter of 2027.

NSX Limited shareholders overwhelmingly approved a scheme of arrangement for acquisition by 1001290557 Ontario Inc., a related entity of the Canadian Stock Exchange operator CNSX Markets Inc. The deal, valued at four cents per fully paid share, now awaits Federal Court approval to proceed.

Kingsgate Consolidated updates its 2025 Mineral Resources and Ore Reserves, introducing a maiden estimate for the Chatree South-East Complex while reporting modest declines in overall Ore Reserves.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.

Orthocell Limited has reported a record $3 million quarterly revenue, driven by strong sales of its nerve repair product Remplir in Australia and Singapore, while advancing its rollout in the US and Canada ahead of schedule.

Pacific Smiles Group has agreed to an unconditional $2.20 per share cash takeover offer from its majority shareholder Genesis Bidco, representing a 37.5% premium. The Independent Board Committee recommends shareholders accept the offer, pending no superior proposal and ongoing fairness confirmation.

ABx Group’s subsidiary ABx3 has received a $2.7 million investment from Good Importing International, granting GII 70% ownership to develop the Sunrise Bauxite Project in Queensland. This funding kickstarts a 12–24 month program targeting regulatory approvals and mine planning, with further investment options on the horizon.

Moab Minerals is set to acquire full ownership of Imbas Mining, unlocking rights to earn up to 80% of the Sasare Gold and Copper Project in Zambia, a site with notable historic gold production and promising copper targets. The acquisition paves the way for an initial exploration campaign targeting both gold and copper mineralisation.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.